Search results
Florida has a fentanyl problem on its shores
Tampa Bay Times· 2 days agoThe best way to keep the drugs killing Americans out of Florida is to stop them well before they reach our shores by working with partners in the region...
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
Motley Fool via Yahoo Finance· 1 day agoCan Recursion accelerate the time frame for drug discovery? Last year, Recursion announced that tech...
Acid for the ear
Politico· 21 hours agoResearchers at the symposium presented their findings on concepts such as gene and cell therapy, developments on medical devices for stroke patients and...
3 Dow Stocks That Are No-Brainer Buys in June
Motley Fool via Yahoo Finance· 1 day agoEven though brand-name therapies only have a finite period of sales exclusivity, novel drugs deliver juicy margins and exceptional pricing power....
Fox News AI Newsletter: The secret to better sleep
Fox News via Yahoo News· 3 days ago- ChatGPT down for some users, OpenAI says - Is this 4-wheel security robot about to replace human security guards? HIGH-TECH ZZZs: Artificial ...
Cathie Wood Owns These 2 AI Stocks. Should You?
Motley Fool via Yahoo Finance· 5 days agoThe company also partnered with Nvidia to create generative AI applications designed to help in drug discovery. The deal came with a $50 million equity...
Google Hires Weight Loss Drug Exec With Zero Tech Experience as New CFO
Futurism via Yahoo Finance· 20 hours agoCapital Gains After a nearly year-long search, Google's parent company has found its next chief...
With Trump endorsement and lead, Rogers tries to fend off rivals in US Senate race
Detroit Free Press via Yahoo News· 1 day agoHe voted against the Affordable Care Act and for its repeal. But he also was willing to work with...
Richard Li's FWD keeps 'close eye' on market amid rumours insurer will refile for IPO
South China Morning Post via Yahoo Finance· 2 days agoInsurer FWD Group Holdings said it is keeping "a close eye" on market conditions amid speculation...
3 Dow Stocks That Are No-Brainer Buys in June
The Motley Fool via AOL· 1 day agoEven though brand-name therapies only have a finite period of sales exclusivity, novel drugs deliver juicy margins and exceptional pricing power....
